Skip to content
DraconiticResearch
Search Sources API
209,918 studies31 sourcesUpdated 46 min ago

Oncology

5,300 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,300 studies

  1. Application of machine learning to identify risk factors for bloodstream infections caused by different antimicrobial resistance phenotypes in chemotherapy patients.
    Adhemar Villani Junior, Maristela P Freire, Luis Alberto De Padua Covas Lage +5
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerPeer-reviewedCC BYFull textOncologyEurope PMC
  2. Revisiting Ehrlich carcinoma in the era of precision oncology: bridging classical models with modern systems biology.
    Varshini Manjunath, Rachana Rajesh Nayak, Ananth Koushik Bhujanga +2
    Medical oncology (Northwood, London, England)Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  3. Combination of oral fluoropyrimidines and EGFR-directed antibodies in frail patients with metastatic colorectal cancer: a systematic review.
    Alena Annbalou Hasenburg, Sebastian Stintzing, Arndt Stahler
    Journal of cancer research and clinical oncologyPeer-reviewedCC BYFull textOncologyEurope PMCDOAJ
  4. Neutrophil-epithelial niches arrest B-cell maturation in dysfunctional tertiary lymphoid structures of gastric cancer neoadjuvant immunochemotherapy.
    Chen Wei, Qiang Fu, Hejia Wei +9
    Journal for immunotherapy of cancerPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  5. Evaluating [¹⁸F]-AlF-FAPI-74 PET/CT for diagnosis of the unfavourable CMS4 colorectal cancer subtype (FoCus study): protocol for a prospective, observational, proof-of-concept clinical study.
    Maurice van Duijvenvoorde, Onno Kranenburg, Myrna van den Bos +15
    BMJ openPeer-reviewedCC BY-NCFull textOncologyEurope PMCCrossref
  6. Age-specific survival after breast conservation versus mastectomy for ductal carcinoma in situ of the breast.
    Jana de Boniface, Robert Szulkin, Per Karlsson +1
    Breast cancer research and treatmentPeer-reviewedCC BYFull textOncologyEurope PMC
  7. Macrophage dysregulation in medication-related osteonecrosis of the jaw: jaw-specific osteoimmune mechanisms and therapeutic perspectives
    Quan Wang, Shensui Li, Changfeng Linghu +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  8. NF-κB signaling as a central integrator of inflammation, stress-induced metabolic dysfunction, and cardiomyocyte fate in sepsis-induced myocardial injury
    Haitang Liao, Yuling Zhou, Xiangwen Weng +5
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  9. Spatial ligand–receptor circuits in osteosarcoma: immune resistance in bone and lung niches
    Yijian Qiu, Shuai Deng, Junfeng Zhou +5
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  10. Closing the adaptive window: immune–metabolic strategies to constrain melanoma therapy resistance
    Federica Riccardo, Laura Conti, Paola Defilippi +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  11. Research advances in Janus kinase inhibitors for immune checkpoint inhibitors-related myocarditis
    Jing Leng, Chenyu Wang, Chunmei Bai
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  12. Discordance of PD-L1 expression between primary and paired metastatic non-small cell lung cancer: a systematic review and meta-analysis
    Leichao Zhang, Yiyao Gao, Xuemei Wang +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  13. Engineering ex vivo T-cell expansion for CAR-T therapy: bridging biological fidelity and bioprocess scalability through platforms, functional consumables, and integrated closed manufacturing
    Qingzhi Wu, Menghui Jiang, Yuanyuan Li +10
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  14. Advancing toxicity prediction in CAR-T cell therapy
    Andrea Palasciano, Stefano Bonfanti, Stefano Crippa
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  15. Editorial: Predictive biomarkers to immune checkpoint inhibitors in lung cancer
    Alessandro Russo, Christian Rolfo, Mariacarmela Santarpia
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  16. Hypoxic Microenvironment Effects on Matrix Metalloproteinases’ Expression and Enzymatic Activity, and HIFs’ Expression in Non-Small Cell Lung Cancer Cells
    Georgina Gonzalez-Avila, Cuauhtemoc Sandoval, Bettina Sommer +5
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  17. lncRNA SNHG29-RPS-CYLD axis is mitochondrially localized and mediates apoptosis in rituximab-resistant DLBCL
    Xin Xu, Xia Wang, Huifang He +7
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  18. Head-to-head comparison of [18F]FAPI and [18F]FDG PET/CT in the clinical value of hepatocellular carcinoma
    Ren Zhang, Lu Li, Wangzheng Liu +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  19. Should we wait?-timing of SRS in EGFR-mutant NSCLC.
    Michael T Milano, Amit K Chowdhry, Nicholas J Denunzio +1
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  20. Rational triplet therapy after CDK4/6 inhibition: what TAKTIC adds and what it cannot resolve.
    Jessé Lopes da Silva, Thales de Sousa Ferreira da Silva, Andréia Cristina de Melo
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  21. Dual context attentive feature network: an interpretable dual-pathway deep learning framework for accurate gastrointestinal endoscopic image classification.
    Omar AlOmair, Zohaib Khurshid
    Quantitative imaging in medicine and surgeryPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  22. Fibrin microstructures reveal differential pericellular fibrin degradation in breast cancer cells.
    Jamie A G Hamilton, Nathan Ocampo, Soojung Lee +1
    Biomaterials and biosystemsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  23. MiR-145 reprogramming facilitates fibrotic trajectory in the tumor microenvironment
    Zhao Lin, Megan Bennett, Patrick Tassone +2
    Frontiers in Cell and Developmental BiologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  24. Elevated human epididymis protein 4 levels in chronic kidney disease compromise the accuracy of the risk of ovarian malignancy algorithm
    Da-Hye Ju, Se-Won Kim, Sang Wook Yi +3
    Experimental and Therapeutic MedicinePeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  25. Activation of the endocytosis pathway stratifies subtypes and therapeutic sensitivity in colorectal cancer
    Hiroyuki Arai, Andrew Elliott, Yan Yang +22
    OncogenePeer-reviewedCC BY 4.0Full textOncologyPMC